A catalyst for public-private partnerships in vaccine related research and business
Previous Flanders Vaccine’s event:
Did you miss our last webinar? Recording is now available.
Over 500 participants joined the Flanders Vaccine Scientific webinar on COVID-19 Vaccines on March 11, 2021.
If you missed out, don’t worry!
Watch the recording which is also available on youtube. Slides are available on request.
Tools for collaboration
We want to stimulate innovation in the development of immunotherapeutics and vaccines by catalyzing new public-private partnerships between knowledge centers, health organisations, pharmaceutical and biotech companies. This should reinforce the leading position in the development and improvement of vaccines for both prevention as well as therapy of a wide range of diseases.
Boost your knowledge
Research, development and production of vaccines and immunotherapeutics is a complex process involving a multidisciplinary field of expertise. An overview of institutions offering courses and training programmes in relevant aspects related to vaccinology can be found here.
Flanders Vaccine supports the development of immunotherapeutics and vaccines for both prophylactic and therapeutic targets in humans and animals by facilitating the exchange of know-how and complementary innovative technologies between academia and industry. The Flanders Vaccine platform can be seen as an integrated tool that gives rise to more and better partnerships.